AVERA MARSHALL REGIONAL MEDICAL CTR (Marshall, MN) prices

Code	Description	Gross	Cash	Min payer	Max payer	# insurers
J9347	Tremelimumab-Actl 300 Mg/15 Ml	$175,800	$170,526	—	—	4
J9347	Tremelimumab-Actl 300 Mg/15 Ml	$175,800	$170,526	—	—	7
J2350	Ocrelizumab 300 Mg/10 Ml	$89,422	$86,740	—	—	4
J2350	Ocrelizumab 300 Mg/10 Ml	$89,422	$86,740	—	—	10
J9309	Polatuzumab Ved-Piiq 140 Mg Vl	$82,774	$80,291	—	—	4
J9309	Polatuzumab Ved-Piiq 140 Mg Vl	$82,774	$80,291	—	—	7
J9334	Efgart-Hyalu-QVFC 1008Mg/5.6Ml	$71,128	$68,995	—	—	4
J9334	Efgart-Hyalu-QVFC 1008Mg/5.6Ml	$71,128	$68,995	—	—	8
J9316	Pertuzu-Trastuzu 15 Ml Vial	$59,046	$57,276	—	—	4
J9316	Pertuzu-Trastuzu 15 Ml Vial	$59,046	$57,276	—	—	7
J3245	Tildrakizumab-ASMN 100Mg/Ml Sy	$56,787	$55,084	—	—	4
J3245	Tildrakizumab-ASMN 100Mg/Ml Sy	$56,787	$55,084	—	—	7
J9042	Brentuximab Vedotin 50 MG Vial	$52,439	$50,867	—	—	4
J9042	Brentuximab Vedotin 50 MG Vial	$52,439	$50,867	—	—	7
J9272	Dostarlimab-Gxly 500 Mg/10 Ml	$52,009	$50,450	—	—	4
J9272	Dostarlimab-Gxly 500 Mg/10 Ml	$52,009	$50,450	—	—	7
J9022	Atezolizumab 1200 Mg/20 Ml Vl	$49,741	$48,249	—	—	4
J9022	Atezolizumab 1200 Mg/20 Ml Vl	$49,741	$48,249	—	—	7
J2329	Ublituximab-Xiiy 150 Mg/6 Ml	$48,610	$47,152	—	—	4
J2329	Ublituximab-Xiiy 150 Mg/6 Ml	$48,610	$47,152	—	—	8
J2327	Risankizumab-Rzaa 600 Mg/10 Ml	$45,613	$44,245	—	—	4
J2327	Risankizumab-Rzaa 600 Mg/10 Ml	$45,613	$44,245	—	—	7
J9144	Daratumumab Hyaluronida 1800Mg	$45,338	$43,978	—	—	4
J9144	Daratumumab Hyaluronida 1800Mg	$45,338	$43,978	—	—	8
J1930	Lanreotide Acet 120MG/0.5ML Sy	$43,179	$41,884	—	—	4
J1930	Lanreotide Acet 120MG/0.5ML Sy	$43,179	$41,884	—	—	7
J3380	Vedolizumab 300 MG Vial	$40,293	$39,085	—	—	4
J3380	Vedolizumab 300 MG Vial	$40,293	$39,085	—	—	9
J9228	Ipilimumab 5 MG/ML 10 ML Vial	$39,314	$38,135	—	—	4
J9228	Ipilimumab 5 MG/ML 10 ML Vial	$39,314	$38,135	—	—	7
J9301	Obinutuzumab 1000 MG/40ML Vial	$37,540	$36,414	—	—	4
J9301	Obinutuzumab 1000 MG/40ML Vial	$37,540	$36,414	—	—	7
J2323	Natalizumab 300 MG/15 ML Vial	$37,092	$35,979	—	—	4
J2323	Natalizumab 300 MG/15 ML Vial	$37,092	$35,979	—	—	8
J9223	Lurbinectedin 0.1 Mg	$36,525	$35,429	—	—	4
J9223	Lurbinectedin 0.1 Mg	$36,525	$35,429	—	—	7
J9299	Nivolumab 240 Mg/24 Ml Vial	$34,019	$32,999	—	—	4
J9299	Nivolumab 240 Mg/24 Ml Vial	$34,019	$32,999	—	—	8
J3101	Tenecteplase 50 Mg/10 Ml Syrng	$31,584	$30,637	—	—	4
J3101	Tenecteplase 50 Mg/10 Ml Syrng	$31,584	$30,637	—	—	8
J0741	Cabotegravir 600 Mg/3 Ml/Rilpi	$29,956	$29,058	—	—	4
J0741	Cabotegravir 600 Mg/3 Ml/Rilpi	$29,956	$29,058	—	—	7
J9306	Pertuzumab 420 MG/14 ML Vial	$29,871	$28,975	—	—	4
J9306	Pertuzumab 420 MG/14 ML Vial	$29,871	$28,975	—	—	8
J2427	Paliperidone Palmitate 546 Mg	$28,341	$27,491	—	—	4
J2427	Paliperidone Palmitate 546 Mg	$28,341	$27,491	—	—	7
J9271	Pembrolizumab 100 MG/4 ML Vial	$25,945	$25,167	—	—	4
J9271	Pembrolizumab 100 MG/4 ML Vial	$25,945	$25,167	—	—	10
J0717	Certolizumab Pegol 400 Mg Kit	$25,886	$25,110	—	—	4
J0717	Certolizumab Pegol 400 Mg Kit	$25,886	$25,110	—	—	8

Showing top 50 of 6,109 priced procedures, sorted by gross charge.

Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.